Michael Toth is a seasoned biopharmaceutical executive with over 25 years of experience in commercial, marketing, and sales. Currently serving as Vice President and Head of US Strategy at Galapagos, they focus on innovative approaches in cell therapy for oncology. Previously, Michael held various leadership roles at Novartis, driving successful strategies in global oncology and hematology, contributing to significant revenue growth and product launches. Their career spans significant contributions at notable companies, including MOVA Laboratories and Wyeth BioPharma, where they advanced commercial initiatives and market strategies. Michael is committed to building high-performing teams and ensuring patient impact through collaboration and strategic planning.
This person is not in the org chart
This person is not in any teams
This person is not in any offices